Literature DB >> 10029616

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

M Thumshirn1, M Camilleri, M G Choi, A R Zinsmeister.   

Abstract

BACKGROUND & AIMS: Disturbed gastric accommodation and sensation contribute to postprandial symptoms in dyspepsia, but the controlling mechanisms are unclear. Nitrergic and alpha2-adrenergic modulation of gastric sensory and motor function were assessed in this study.
METHODS: Using a factorial design, we assessed drug effects on gastric sensation during isobaric distentions and fasting and postprandial gastric motor function in 32 healthy volunteers. Each participant received one treatment: placebo; 0.3 or 0.5 microgram. kg-1. min-1 intravenous nitroglycerin; 0.0125, 0.025, or 0.1 mg clonidine orally; or combined nitroglycerin plus clonidine. In 16 other healthy subjects, the effects of clonidine and placebo on gastric emptying of solids were evaluated using the 13C-octanoic acid breath test.
RESULTS: Clonidine and nitroglycerin increased gastric compliance, but normal postprandial accommodation was still observed despite the induced relaxation. Clonidine but not nitroglycerin reduced aggregate and pain perception averaged over four distention levels. There were no significant drug interactions. No dose effect of clonidine was observed on gastric emptying.
CONCLUSIONS: Clonidine relaxes the stomach and reduces gastric sensation without inhibiting accommodation or emptying. Nitroglycerin relaxes the stomach without altering perception. Studies of the effects of clonidine on these gastric functions and symptoms in disease are warranted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029616     DOI: 10.1016/s0016-5085(99)70179-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  45 in total

1.  SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography.

Authors:  E P Bouras; S Delgado-Aros; M Camilleri; E J Castillo; D D Burton; G M Thomforde; H J Chial
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

3.  Fundic accommodation assessed by SPECT scanning: comparison with the gastric barostat.

Authors:  B D J van den Elzen; R J Bennink; R E Wieringa; G N J Tytgat; G E E Boeckxstaens
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

Review 4.  Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.

Authors:  M Camilleri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 5.  Non-invasive measurement of gastric accommodation in humans.

Authors:  W Schwizer; A Steingötter; M Fox; T Zur; M Thumshirn; P Bösiger; M Fried
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 6.  New therapies for functional bowel diseases.

Authors:  B Coulie; M Camilleri
Journal:  Curr Gastroenterol Rep       Date:  2000-10

7.  Advances in the management of gastroparesis.

Authors:  Frank K Friedenberg; Henry P Parkman
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

8.  Electroacupuncture restores impaired gastric accommodation in vagotomized dogs.

Authors:  Hui Ouyang; Jinhong Xing; Jdz Chen
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Treatment of Functional Dyspepsia.

Authors:  Christine Feinle-Bisset; Jane M. Andrews
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

10.  Assessment of Gastric Accommodation by SPECT.

Authors:  Sung Pyo Hong
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.